Atropine Sulphate
Welcome to Dwaey, specifically on Atropine Sulphate page.
This medicine contains important and useful components, as it consists of
Atropine Sulphate is available in the market in concentration.
Generic Name of Atropine Sulphate - Learn More
Atropine Sulphate
Atropine Sulphate Precaution - What You Need to Know
Atropine sulfate is a muscarinic antagonist primarily used to treat bradycardia, as well as to reverse the effects of muscarinic poisoning (e.g., from organophosphate pesticides). Caution should be used when administering atropine to patients with a history of glaucoma, particularly angle-closure glaucoma, as atropine can increase intraocular pressure, exacerbating this condition. It should also be avoided or used with great caution in patients with pre-existing heart conditions, especially those with tachyarrhythmias, as atropine can cause an increased heart rate. In elderly patients, atropine can cause confusion, agitation, or delirium, and careful monitoring is required. For patients with myasthenia gravis, atropine may worsen symptoms due to its anticholinergic effects. Patients with a history of gastrointestinal obstructions (such as pyloric stenosis or paralytic ileus) should be carefully monitored when using atropine, as it may decrease motility, leading to constipation or ileus. Atropine should also be used cautiously in patients with renal or hepatic dysfunction, as these patients may have altered drug metabolism. Pregnant and breastfeeding women should only use atropine if absolutely necessary, as it can cross the placenta and be excreted in breast milk, though it is generally considered a Category C drug (risk cannot be ruled out). It is also important to monitor for signs of atropine toxicity, including dry mouth, urinary retention, blurred vision, and confusion.
Atropine Sulphate Indication - Uses and Benefits
Atropine sulfate is primarily indicated for the treatment of bradycardia (slow heart rate) to prevent and treat symptomatic or hemodynamically significant bradycardia, particularly in emergency situations. It is also used to treat organophosphate poisoning (e.g., from pesticides or nerve agents) by blocking the effects of acetylcholine at the muscarinic receptors, counteracting the excessive cholinergic stimulation caused by these substances. Atropine is utilized as a pre-anesthetic medication to prevent excessive salivation and bronchial secretion in patients undergoing surgery, particularly in pediatric patients, and can be used to treat certain types of poisoning caused by cholinergic agents. Additionally, atropine is used to reverse the effects of neuromuscular blockers like succinylcholine, which may cause bradycardia during anesthesia. It can also be used to treat excessive vagal tone or certain types of heart block that are unresponsive to pacing. Off-label uses of atropine include the treatment of acute myocardial infarction (heart attack) to improve hemodynamics by increasing heart rate and reducing the incidence of bradyarrhythmias.
Atropine Sulphate Contraindications - Important Warnings
Atropine sulfate is contraindicated in patients with known hypersensitivity to atropine or any of its components. It should not be used in patients with narrow-angle glaucoma, as atropine can worsen this condition by increasing intraocular pressure. It is also contraindicated in patients with gastrointestinal obstruction, paralytic ileus, or any condition that might exacerbate the risk of bowel perforation, as atropine may decrease gastrointestinal motility. In patients with myasthenia gravis, atropine should be avoided due to the risk of exacerbating muscle weakness. Atropine is contraindicated in patients with tachyarrhythmias, such as supraventricular tachycardia, where increasing the heart rate may worsen the arrhythmia. Patients with severe hepatic or renal impairment should use atropine with caution, as its elimination could be delayed in these conditions. In addition, atropine is not recommended for use in individuals with a history of hypersensitivity reactions to anticholinergic drugs, as these may predispose to an allergic reaction. Atropine should not be used during the treatment of poisoning caused by other agents that affect the sympathetic nervous system (e.g., certain tricyclic antidepressants) without careful monitoring.
Atropine Sulphate Side Effects - What to Expect
Common side effects of atropine sulfate are generally related to its anticholinergic properties and include dry mouth, blurred vision, sensitivity to light, urinary retention, and constipation. These effects are typically mild but can be bothersome for patients. More serious, though less common, side effects include tachycardia (increased heart rate), especially in patients with underlying cardiovascular conditions, and confusion or delirium, particularly in elderly patients. In severe cases, atropine toxicity can occur, presenting as "hot as a hare, blind as a bat, dry as a bone, red as a beet, and mad as a hatter," which refers to the symptoms of hyperthermia, blurred vision, dry mouth and skin, flushed skin, and altered mental status. If toxicity occurs, the antidote (physostigmine) should be administered, and supportive care may be required. In rare cases, anaphylaxis or severe allergic reactions have been reported, including difficulty breathing, swelling of the face or throat, and hives. Prolonged use or high doses of atropine may exacerbate pre-existing glaucoma, lead to urinary retention, or worsen symptoms in patients with gastrointestinal conditions such as paralytic ileus. Patients should be instructed to report any side effects, particularly those affecting their vision, urinary habits, or cognitive function.
Atropine Sulphate Pregnancy Category ID - Safety Information
3
Atropine Sulphate Mode of Action - How It Works
Atropine sulfate works by blocking the action of acetylcholine at muscarinic receptors, which are part of the parasympathetic nervous system. These receptors are found in various tissues, including the heart, smooth muscles, and glands. By inhibiting acetylcholine binding to these receptors, atropine prevents the typical parasympathetic effects such as slowed heart rate, increased secretion from glands, and smooth muscle contraction. In the heart, atropine blocks the vagal (parasympathetic) influence, leading to an increase in heart rate. This effect is particularly beneficial in the treatment of bradycardia (slow heart rate) or heart block. Atropine’s effects on the smooth muscles of the gastrointestinal tract reduce motility, which can be useful in some clinical settings, such as managing organophosphate poisoning or as a pre-anesthetic medication to reduce salivation and bronchial secretions. Its actions are also evident in the eye, where it induces pupil dilation (mydriasis) by inhibiting the parasympathetic control of the iris sphincter muscle. The drug is rapidly absorbed when administered parenterally, and its effects typically begin within minutes, with a duration that can last several hours depending on the dose and the clinical condition.
Atropine Sulphate Drug Interactions - What to Avoid
Atropine sulfate may interact with other medications that affect the parasympathetic nervous system, especially those with anticholinergic properties. Combining atropine with other anticholinergic agents (e.g., antihistamines, tricyclic antidepressants, certain antipsychotics, or muscle relaxants) may enhance its effects, leading to severe dry mouth, urinary retention, constipation, or confusion. The combination of atropine with other drugs that can increase heart rate, such as sympathomimetics (e.g., epinephrine), should be carefully monitored to avoid an excessive increase in heart rate or arrhythmias. Atropine may also interact with medications that have sedative or CNS-depressant effects, such as benzodiazepines or barbiturates, potentially enhancing their sedative effects and causing drowsiness or confusion, especially in elderly patients. In patients taking digoxin or other cardiac glycosides, atropine may increase the risk of arrhythmias, so caution is advised. The use of atropine with cholinesterase inhibitors (e.g., neostigmine) can counteract the effects of atropine, as these drugs increase acetylcholine levels, while atropine works to block acetylcholine's effects. When atropine is used to treat organophosphate poisoning, additional care is needed if the patient is concurrently on other medications that influence cholinergic function.
Atropine Sulphate Adult Dose - Recommended Dosage
The adult dose of atropine sulfate depends on the indication for its use. For bradycardia, the typical initial dose is 1 mg administered intravenously (IV), which may be repeated every 3-5 minutes up to a total of 3 mg as needed to achieve the desired heart rate response. For organophosphate poisoning, an initial dose of 1-2 mg IV is recommended, with further doses administered every 10-30 minutes as required to control symptoms, depending on the severity of the poisoning. As a pre-anesthetic medication to reduce secretions, the dose is typically 0.4-0.6 mg IV administered 30-60 minutes before surgery. In cases where atropine is used to reverse the effects of neuromuscular blocking agents like succinylcholine, the recommended dose is usually 0.4-1 mg IV. The dose should be individualized depending on the clinical situation, and patients should be closely monitored for side effects such as tachycardia or confusion, particularly in older adults.
Atropine Sulphate Child Dose - Dosage for Children
The typical dose of atropine sulfate for children depends on the clinical indication and the child's weight. For bradycardia, the recommended initial dose is 0.02 mg/kg IV, with a minimum dose of 0.1 mg and a maximum dose of 0.5 mg per administration. This dose can be repeated as necessary, up to a total dose of 1 mg. In cases of organophosphate poisoning, the initial dose for children is typically 0.05 mg/kg IV, which can be repeated as needed, similar to adults, to manage symptoms. For pre-anesthetic medication, the dose ranges from 0.01 to
0.02 mg/kg, usually administered 30-60 minutes before surgery. Careful dosing and monitoring are critical in children, as they are more sensitive to the anticholinergic effects of atropine, and overdose can lead to severe complications such as tachycardia, delirium, or hyperthermia.
Atropine Sulphate Renal Dose - Dosage for Kidney Conditions
Atropine sulfate is not primarily eliminated through the kidneys but is excreted via the liver, so renal impairment typically does not require significant dosage adjustments. However, patients with renal failure should be monitored closely for potential accumulation of the drug or its metabolites, as this could prolong the effects. In severe renal impairment, atropine’s effects may be prolonged, and smaller doses may be considered based on clinical response. It is important to adjust the dose and frequency of administration based on the severity of the patient’s condition and their overall clinical status. Monitoring of heart rate, mental status, and urinary function is advised in patients with renal dysfunction receiving atropine.
